TGA Suspends Supply of Corpuls Defibrillators

Australia's Therapeutic Goods Administration has suspended further supply of the Corpuls 3 and 3T defibrillation systems for three months, after reports that units carried by ambulance services — including in New South Wales — were unexpectedly shutting down and rebooting during use. The TGA was careful to draw a line between the action it took and a recall: existing devices, it said, remain safe to use and can keep being serviced, and no serious patient harm has been tied to the reported faults.

A precautionary action, deliberately short of a recall

The TGA's own framing is the story here as much as the underlying device issue. Its 12 August statement acknowledged that media reports about defibrillator safety “may cause concern” to a public that relies on these devices in emergencies, and moved quickly to draw a distinction: the agency suspended further supply of the corpuls3 and corpuls3T system under the section of the Therapeutic Goods Act that applies when there are grounds to believe an entry could be cancelled from the Australian Register of Therapeutic Goods — but explicitly said this is not a finding that the devices are unsafe, and that it has not recalled them. Devices already deployed can keep being used and serviced through the suspension period; the only immediate effect is that no new units can be supplied into the Australian market until 25 November 2026, giving the manufacturer time to resolve the underlying concern.

What NSW ambulance crews reported

The concerns trace to reports that Corpuls 3 and 3T units — used by ambulance services including in New South Wales — were unexpectedly shutting down and rebooting during use, with malfunctions logged over recent years. NSW Ambulance's executive director of clinical capability, Alan Morrison, characterized the range of reported technical issues as spanning from minor hardware problems such as clips, clamps, and connectors up to more serious faults, while stressing that the health service was “not talking about a large number of defibrillation failures.” NSW Health Minister Ryan Park separately said there had been no reports of deaths or serious harm linked to the device faults in the state.

Why a supply suspension still matters for RA teams

A three-month, non-recall supply suspension is a lighter-touch action than most of the device alerts that make headlines, but the mechanism is worth tracking on its own terms: the TGA reached for section 41GA(1)(b) — grounds to cancel an ARTG entry — as a faster, reversible lever short of a full cancellation or recall, while a manufacturer works through a fix. For device sponsors watching international precedent, it is a data point on how a major regulator handles field-malfunction reports for a widely deployed emergency-care device without freezing the installed base: existing units keep operating, new supply pauses, and the clock resets against a defined date rather than an open-ended investigation.